1. Jackson, J.R., et al., Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J. Pharmacol. Exp. Ther. 284, 687, (1998) 2. Wang, Z., et al., Structural basis of inhibitor selectivity in MAP kinases. Structure 6, 1117, (1998)